Article

Dr. Lee becomes new U-M chairman

Paul P. Lee, MD, JD, has been appointed chairman of the ophthalmology and visual sciences department and holder of the F. Bruce Fralick Professorship at the University of Michigan, Ann Arbor.

Ann Arbor, MI-Paul P. Lee, MD, JD, has been appointed chairman of the ophthalmology and visual sciences department and holder of the F. Bruce Fralick Professorship at the University of Michigan (U-M), Ann Arbor.

“An outstanding clinician and innovative leader, Dr. Lee is ideally suited to head a department that has grown rapidly and just recently opened a magnificent new facility for eye care, education, and vision research,” said James O. Woolliscroft, MD, dean of the U-M Medical School.

As chairman, Dr. Lee succeeds glaucoma specialist Paul R. Lichter, MD, who served in the role for 34 years and has been a mentor to Dr. Lee since his medical school days.

“The terrific work of Dr. Paul Lichter and the faculty positions us to help reshape the future of vision health and eye care,” Dr. Lee said. “It is a special privilege to help build on what he and the department have already accomplished.”

Dr. Lee previously was vice chairman of the ophthalmology department and the James Pitzer Gills III, MD, and Joy Gills Professor of Ophthalmology at Duke University, Durham, NC. In addition, he held appointments as director of applied health systems research for the Duke University Health System and as senior adviser to the chancellor. Among other administrative leadership positions at Duke, Dr. Lee was chairman of the finance committee of the physician practice and member of the executive management committee of the Duke University Health System.

Before joining Duke in 1997, Dr. Lee was with RAND, a nonprofit research organization in Santa Monica, CA, and was an associate professor at the University of Southern California School of Medicine.

Dr. Lee earned his medical degree from U-M and his law degree from Columbia University in 1986. He completed an internship in internal medicine at Harvard Medical School’s Beth Israel Hospital, Boston, and his ophthalmology residency at the Wilmer Eye Institute of Johns Hopkins Hospital, Baltimore. After his residency, Dr. Lee completed a glaucoma fellowship at the Massachusetts Eye and Ear Infirmary, Boston.

The new chairman serves on the American Board of Ophthalmology Board of Directors and also maintains a referral clinical practice for patients with complex cases of glaucoma.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.